Tirzepatida y retatrutida: nueva frontera La tirzepatida, agonista dual GLP-1/GIP, tambin retrasa el vaciamiento gstrico, aunque este efecto parece disminuir despus de 23 das de tratamiento
27 Because Fer-1 was more potent than lipophilic or soluble antioxidants, it was hypothesized that its aromatic amine structure may confer a unique profile of radical reactivity upon Fer-1 that is better tuned to the RSL mechanism
The concern is about early worsening during the first several months of rapid glucose improvement, not the long-term effects
These include facilitating glucose reduction, delaying gastric motility, improving insulin responsiveness, and inhibiting glucagon production (Meier, 2012)
Rarely, rashes or skin reactions have been reported
The distension from gas and retained food is not adding body fat